|
| 36884224 | Prognostic Value of Cutaneous Disease Severity Estimates on Survival Outcomes in Patients With Chronic Graft-vs-Host Disease. | JAMA Dermatol | 2023 |
| 37589970 | Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. | JAMA Oncol | 2023 |
| 37159277 | Racial Differences in the Association of Endometriosis and Uterine Leiomyomas With the Risk of Ovarian Cancer. | Obstet Gynecol | 2023 |
| 34756753 | Human Papillomavirus Vaccine Impact on Cervical Precancers in a Low-Vaccination Population. | Am J Prev Med | 2022 |
| 35654411 | Race Differences in the Associations between Menstrual Cycle Characteristics and Epithelial Ovarian Cancer. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 35633315 | Racial disparities in epithelial ovarian cancer survival: An examination of contributing factors in the Ovarian Cancer in Women of African Ancestry consortium. | Int J Cancer | 2022 |
| 35416993 | Evaluation of Information Theoretic Network Meta-analysis to Rank First-Line Anticancer Regimens for Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer. | JAMA Netw Open | 2022 |
| 36402776 | Integrating transcription factor occupancy with transcriptome-wide association analysis identifies susceptibility genes in human cancers. | Nat Commun | 2022 |
| 36210504 | Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. | J Natl Cancer Inst | 2022 |
| 36138071 | Racial differences in the association of body mass index and ovarian cancer risk in the OCWAA Consortium. | Br J Cancer | 2022 |
| 36093688 | Multiplex immunohistochemistry and high-throughput image analysis for evaluation of spatial tumor immune cell markers in human breast cancer. | Cancer Biomark | 2022 |
| 36077869 | Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study. | Cancers (Basel) | 2022 |
| 35088206 | A pooled case-only analysis of obesity and breast cancer subtype among Black women in the southeastern United States. | Cancer Causes Control | 2022 |
| 35338704 | Association of Leukocyte Adhesion and Rolling in Skin With Patient Outcomes After Hematopoietic Cell Transplantation Using Noninvasive Reflectance Confocal Videomicroscopy. | JAMA Dermatol | 2022 |
| 35262738 | Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19. | Blood Cancer Discov | 2022 |
| 34893494 | Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer. | Cancer Discov | 2022 |
| 32359158 | Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk. | J Natl Cancer Inst | 2021 |
| 33521947 | First- and second-degree family history of ovarian and breast cancer in relation to risk of invasive ovarian cancer in African American and white women. | Int J Cancer | 2021 |
| 33524941 | Prevalence of Anemia and Compliance With NCCN Guidelines for Evaluation and Treatment of Anemia in Patients With Gynecologic Cancer. | J Natl Compr Canc Netw | 2021 |
| 34439369 | The Impact of the Human Papillomavirus Vaccine on High-Grade Cervical Lesions in Urban and Rural Areas: An Age-Period-Cohort Analysis. | Cancers (Basel) | 2021 |
| 34438316 | Increasing Area Deprivation Index negatively impacts ovarian cancer survival. | Cancer Epidemiol | 2021 |
| 34638514 | High-Fat Diet-Induced Obese Effects of Adipocyte-Specific CXCR2 Conditional Knockout in the Peritoneal Tumor Microenvironment of Ovarian Cancer. | Cancers (Basel) | 2021 |
| 34155063 | Genital Powder Use and Risk of Epithelial Ovarian Cancer in the Ovarian Cancer in Women of African Ancestry Consortium. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33947654 | A Pooled Case-only Analysis of Reproductive Risk Factors and Breast Cancer Subtype Among Black Women in the Southeastern United States. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 34162658 | Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33104988 | Modeling the Impact of Delaying Bariatric Surgery due to COVID-19: a Decision Analysis. | Obes Surg | 2021 |
| 32473302 | Prognostic gene expression signature for high-grade serous ovarian cancer. | Ann Oncol | 2020 |
| 31872213 | A Mendelian randomization analysis of circulating lipid traits and breast cancer risk. | Int J Epidemiol | 2020 |
| 32044108 | CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes. | Gynecol Oncol | 2020 |
| 33142915 | Platelets, Thrombocytosis, and Ovarian Cancer Prognosis: Surveying the Landscape of the Literature. | Int J Mol Sci | 2020 |
| 32974032 | Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis. | Biomark Res | 2020 |
| 32554541 | Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE). | Clin Cancer Res | 2020 |
| 31001917 | Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. | Cancer Med | 2019 |
| 31387969 | Urinary PGE-M Levels and Risk of Ovarian Cancer. | Cancer Epidemiol Biomarkers Prev | 2019 |
| 31236792 | Ovarian Cancer in Women of African Ancestry (OCWAA) consortium: a resource of harmonized data from eight epidemiologic studies of African American and white women. | Cancer Causes Control | 2019 |
| 31402092 | Identifying Putative Susceptibility Genes and Evaluating Their Associations with Somatic Mutations in Human Cancers. | Am J Hum Genet | 2019 |
| 29482584 | Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors. | J Ovarian Res | 2018 |
| 30054336 | A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. | Cancer Res | 2018 |
| 30238071 | SMART Cancer Navigator: A Framework for Implementing ASCO Workshop Recommendations to Enable Precision Cancer Medicine. | JCO Precis Oncol | 2018 |
| 30181917 | Chemokine Network and Overall Survival in <i>TP53</i> Wild-Type and Mutant Ovarian Cancer. | Immune Netw | 2018 |
| 30619633 | Obesity-Induced Peritoneal Dissemination of Ovarian Cancer and Dominant Recruitment of Macrophages in Ascites. | Immune Netw | 2018 |
| 29748761 | Gene expression in triple-negative breast cancer in relation to survival. | Breast Cancer Res Treat | 2018 |
| 29515768 | CXCR2 is a negative regulator of p21 in p53-dependent and independent manner via Akt-mediated Mdm2 in ovarian cancer. | Oncotarget | 2018 |
| 29460995 | The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. | Hum Mutat | 2018 |
| 29029385 | Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci. | Oncotarget | 2017 |
| 28350790 | Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. | Br J Cancer | 2017 |
| 28448592 | Blood type, ABO genetic variants, and ovarian cancer survival. | PLoS One | 2017 |
| 28346442 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer. | Nat Genet | 2017 |
| 27053251 | Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. | Cancer Causes Control | 2016 |
| 26621531 | Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium. | Hum Genet | 2016 |